Data to be presented from the STARt-001 trial demonstrating single agent anti-tumor activity CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ — Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and…

DUBLIN, March 25, 2025 /PRNewswire/ — AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust (together, the “Issuers”), each a wholly-owned subsidiary of AerCap Holdings N.V. (“AerCap” or the “Company”), priced an offering of $500 million aggregate principal…

CHARLOTTE, N.C., March 25, 2025 /PRNewswire/ — Bank of America Corporation announced today that it will redeem on April 2, 2025 all $500,000,000 principal amount outstanding of its Floating Rate Senior Notes, due April 2026 (CUSIP No. 06051GKN8) (the “Floating Rate Notes”), and all…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.